Cargando…
Small-Molecule Synthetic Compound Norcantharidin Reverses Multi-Drug Resistance by Regulating Sonic Hedgehog Signaling in Human Breast Cancer Cells
Multi-drug resistance (MDR), an unfavorable factor compromising treatment efficacy of anticancer drugs, involves upregulated ATP binding cassette (ABC) transporters and activated Sonic hedgehog (Shh) signaling. By preparing human breast cancer MCF-7 cells resistant to doxorubicin (DOX), we examined...
Autores principales: | Chen, Yu-Jen, Kuo, Cheng-Deng, Chen, Szu-Han, Chen, Wei-Jen, Huang, Wen-Chien, Chao, K. S. Clifford, Liao, Hui-Fen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352857/ https://www.ncbi.nlm.nih.gov/pubmed/22615870 http://dx.doi.org/10.1371/journal.pone.0037006 |
Ejemplares similares
-
Targeting Sonic Hedgehog Signaling by Compounds and Derivatives from Natural Products
por: Huang, Yu-Chuen, et al.
Publicado: (2013) -
Norcantharidin, Derivative of Cantharidin, for Cancer Stem Cells
por: Hsieh, Chen-Hsi, et al.
Publicado: (2013) -
Insight into norcantharidin, a small-molecule synthetic compound with potential multi-target anticancer activities
por: Pan, Mu-Su, et al.
Publicado: (2020) -
Resveratrol Downregulates Interleukin-6-Stimulated Sonic Hedgehog Signaling in Human Acute Myeloid Leukemia
por: Su, Yu-Chieh, et al.
Publicado: (2013) -
Discovery of Small-Molecule Modulators of the Sonic
Hedgehog Pathway
por: Schaefer, Giannina I., et al.
Publicado: (2013)